AGP Picks
View all

Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on July 2, 2026

Imposter Syndrome Reexamined in New Book by Kirsten Bombdiggity
Holina Village Cyprus Extends Proven Therapeutic Community Model to Adults Amid UK, Ireland and Middle East Demand
Holina Village Cyprus Enhances Clinical Governance with Expanded Multidisciplinary Team for New Adult Recovery Programme
Cell Grand Clinic Named 'Top Regenerative Medicine Solution Provider in APAC 2026' by Healthcare Business Review APAC
As Australian Frontier Tech Funding Hits Records, CoLabs Brings Sydney the Lab Infrastructure to Match
CoLabs Australia Secures $397,074 to Help DeepTech Founders Build What the Market Actually Wants
Vaccine to Treat ‘Neglected Disease’ Shows Promising Results
THE LUNAR CODEX AND THE INTERNATIONAL LUNAR OBSERVATORY ASSOCIATION TO LAUNCH CULTURAL ARCHIVES TO THE MOON
Vehere Unveils New Multi-Agent AI to Reduce Alert Overload and Improve Analyst Outcomes
Symbotic Announces Acquisition of ARMS Innovations, Advancing a New Era of Warehouse Operations Optimization
Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)
Abivax annonce l’exercice intégral de l’option de souscription d’ADS supplémentaires des teneurs de livre associés, portant le produit brut de l’Offre à 920 M$ (807 M€)
Qoder Introduces Time-of-Day Credits Pricing for Qwen3.7-Max and Qwen3.7-Plus
TomTom and Transit Technologies partner to deliver enhanced fleet and logistics operations
LexisNexis Risk Solutions and Promon Align to Strengthen Mobile Fraud Prevention
Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712
Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering
Pep Club Launches Telehealth Platform Combining Prescription Therapy, Peptide Protocols, and At-Home Biomarker Testing
FDA Alignment to Advance ProstACT Global Phase 3 Trial
GNI Group Completes Acquisition of AYUMI Pharmaceutical

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Science

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.